Company intelligence / Profile preview

FertilAI

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

FertilAI's AI-driven Fertilane platform is clinically validated and integrates with clinic EMRs to improve fertility treatment outcomes, timing, and clinic efficiency. Its real-world use has covered over 100,000 patient records, supported >20,000 treatments in 2024, and enabled improved patient-clinic communication and workflow efficiency across Europe, Asia, the Middle East, and recently expanded to the U.S.[1][2][3][5].

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on FertilAI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FertilAI.

Explore the full profile